Avita Medical terminates CEO Michael Perry, appoints James Corbett as President and CEO

AVITA Medical, Inc.

Dr. Michael Perry terminated as President and CEO effective Sept 28, 2022; he remains a director.
James Corbett appointed President and CEO; previously a non-executive director since July 2021.
Corbett receives $600,000 annual base salary, $1M stock option grant (4-year vest), target bonus 60%.
Corbett has ~40 years med device experience, CEO of Microtherapeutics, ev3, Alphatec Spine.
Initial employment term of 3 years with automatic one-year renewals; Corbett also joins Board as executive.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James Corbett

President and CEO

RCEL · AVITA Medical, Inc.

Effective: 2022-09-28
Filed: September 30, 2022, 7:59 PM ET

Effective September 28, 2022, the Board of Directors of the Company appointed James Corbett as the Company’s President and CEO.

Departed

Michael Perry

President and CEO

RCEL · AVITA Medical, Inc.

Effective: 2022-09-28
Successor: James Corbett
Filed: September 30, 2022, 7:59 PM ET

Effective September 28, 2022, the Board of Directors of Avita Medical, Inc. (the “Company”) terminated the employment of Dr. Michael Perry, the Company’s President and CEO.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Corbett was appointed as President and CEO at AVITA Medical, Inc..

Action: appointed
Role: President and CEO

Exact text from the filing

Effective September 28, 2022, the Board of Directors of the Company appointed James Corbett as the Company’s President and CEO.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Perry was terminated as President and CEO at AVITA Medical, Inc..

Action: terminated
Role: President and CEO

Exact text from the filing

Effective September 28, 2022, the Board of Directors of Avita Medical, Inc. (the “Company”) terminated the employment of Dr. Michael Perry, the Company’s President and CEO.

View on SEC.gov

AVITA Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-254959

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.